Cargando…

Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF): An 8-year Observational Study at a Single Center

Expanded clinical experience with patients taking antiangiogenic compounds has come with increasing recognition of the renal adverse effects. Because renal histology is rarely sought in those patients, the renal consequences are underestimated. Antiangiogenic-treated-cancer patients, who had a renal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izzedine, Hassan, Escudier, Bernard, Lhomme, Catherine, Pautier, Patricia, Rouvier, Philippe, Gueutin, Victor, Baumelou, Alain, Derosa, Lisa, Bahleda, Rastilav, Hollebecque, Antoine, Sahali, Djillali, Soria, Jean Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602430/ https://www.ncbi.nlm.nih.gov/pubmed/25500702 http://dx.doi.org/10.1097/MD.0000000000000207

Ejemplares similares

ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012)

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
por: Négrier, Sylvie, et al.
Publicado: (2017)

Nephrotic Syndrome Associated with Lung Cancer: A Rare Case of Malignancy Associated with AA Amyloidosis
por: Gueutin, Victor, et al.
Publicado: (2013)

Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell Carcinoma
por: Derosa, Lisa, et al.
Publicado: (2016)

Renal thrombotic microangiopathy and FIP1L1/PDGFRα-associated myeloproliferative variant of hypereosinophilic syndrome
por: Langlois, Anne Lyse, et al.
Publicado: (2013)

Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs)
por: Gharbi, Chems, et al.
Publicado: (2014)

Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy
por: Izzedine, Hassane, et al.
Publicado: (2010)

Anti-VEGF Cancer Therapy in Nephrology Practice
por: Izzedine, Hassan
Publicado: (2014)

Unlikely association of nephrectomy post-mRCC with anti-VEGF-induced renal TMA
por: Izzedine, Hassane, et al.
Publicado: (2011)

Renal involvement in idiopathic hypereosinophic syndrome
por: Shehwaro, Nathalie, et al.
Publicado: (2013)

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
por: Bayle, Arnaud, et al.
Publicado: (2021)

Upregulation of Nuclear Factor-Related Kappa B Suggests a Disorder of Transcriptional Regulation in Minimal Change Nephrotic Syndrome
por: Audard, Vincent, et al.
Publicado: (2012)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)

Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours
por: Bahleda, Rastislav, et al.
Publicado: (2015)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF
por: Man, Xiao-Yong, et al.
Publicado: (2008)

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
por: Schmidinger, Manuela
Publicado: (2013)

Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy
por: Lin, Shuhua, et al.
Publicado: (2016)

The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer
por: Goulart, André, et al.
Publicado: (2019)

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998)

Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
por: Herrlinger, U, et al.
Publicado: (2004)

The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
por: Holmes, David IR, et al.
Publicado: (2005)

Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
por: Kurebayashi, Junichi, et al.
Publicado: (1999)

Multiscale modeling of tumor response to vascular endothelial growth factor (VEGF) inhibitor
por: Hendrata, Melisa, et al.
Publicado: (2022)

Modeling the Cluster Size Distribution of Vascular Endothelial Growth Factor (VEGF) Receptors
por: Güven, Emine, et al.
Publicado: (2022)

Heparin-Induced Changes of Vascular Endothelial Growth Factor (VEGF(165)) Structure
por: Nemashkalova, Ekaterina L., et al.
Publicado: (2023)

Expression and correlation analysis of RegIV and vascular endothelial growth factors (VEGF-A and VEGF-C) in metastatic spinal tumors
por: Zhang, Shuquan, et al.
Publicado: (2017)

Paradoxical embolism following thromboaspiration of an arteriovenous fistula thrombosis: a case report
por: Bentaarit, Bouteina, et al.
Publicado: (2010)

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate
por: Pautier, Patricia, et al.
Publicado: (2013)

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
por: Obermair, A., et al.
Publicado: (1998)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
por: Wang, Xun, et al.
Publicado: (2007)

Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease
por: Wieck, Minna M., et al.
Publicado: (2016)

VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43
por: Li, Lufeng, et al.
Publicado: (2017)

The Effect and Mechanism of Vascular Endothelial Growth Factor (VEGF) on Tumor Angiogenesis in Gallbladder Carcinoma
por: XU, Dongqing, et al.
Publicado: (2019)

Automated and Reproducible Detection of Vascular Endothelial Growth Factor (VEGF) in Renal Tissue Sections
por: Macedo, Nayana Damiani, et al.
Publicado: (2019)

Islet vascularization is regulated by primary endothelial cilia via VEGF-A-dependent signaling
por: Xiong, Yan, et al.
Publicado: (2020)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f53mteavh2ia622b2f1l4nr848